POSEIDA THERAPEUTICS INC shareholders Q2 2023

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

POSEIDA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 2,945,948$5,184,8681.60%
Aisling Capital Management LP 1,043,267$1,836,1500.90%
Knott David M Jr 140,921$2480.10%
XTX Topco Ltd 233,493$410,9480.07%
Pentwater Capital Management LP 5,975,000$10,516,0000.07%
Atom Investors LP 49,413$86,9670.03%
EcoR1 Capital, LLC 676,296$1,190,2810.03%
Forefront Analytics, LLC 26,619$46,8500.03%
FNY Investment Advisers, LLC 11,500$200.02%
CORNERCAP INVESTMENT COUNSEL INC 80,979$142,5230.02%
Callan Capital, LLC 72,559$127,7040.01%
GLOBEFLEX CAPITAL L P 66,885$117,7180.01%
GSA CAPITAL PARTNERS LLP 74,040$1300.01%
Advisory Services Network, LLC 257,271$452,7970.01%
TUCKER ASSET MANAGEMENT LLC 19,096$33,6090.01%
RBF Capital, LLC 70,171$123,5010.01%
ACADIAN ASSET MANAGEMENT LLC 1,111,372$1,9540.01%
MCF Advisors LLC 42,854$75,4240.01%
BLAIR WILLIAM & CO/IL 568,740$1,000,9820.00%
OCCUDO QUANTITATIVE STRATEGIES LP 23,427$41,2320.00%
External links

This page lists POSEIDA THERAPEUTICS INC's shareholders in Q2 2023. To view POSEIDA THERAPEUTICS INC's shareholder history, click here.